Review – Recent news on prevention and treatment of gastric cancer

Despite its decreasing incidence, gastric cancer (GC) is still the third leading cause of cancer death in the world. Eradication of Helicobacter pylori has been shown to decrease the risk of GC, without evidence of adverse consequences. Operable GC is treated with surgery, and laparoscopic gastrecto...

Full description

Saved in:
Bibliographic Details
Published in:Microbiota in health and disease 2021-08, Vol.3
Main Authors: G. Pasi, T. Matysiak-Budnik
Format: Article
Language:English
Subjects:
helicobacter pylori
immunotherapy
laparoscopy
prevention
screening
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue
container_start_page
container_title Microbiota in health and disease
container_volume 3
creator G. Pasi
T. Matysiak-Budnik
description Despite its decreasing incidence, gastric cancer (GC) is still the third leading cause of cancer death in the world. Eradication of Helicobacter pylori has been shown to decrease the risk of GC, without evidence of adverse consequences. Operable GC is treated with surgery, and laparoscopic gastrectomy has proven to be a valid alternative to open gastrectomy. For advanced GC, the available therapies show limited benefit in extending survival, but some new approaches are emerging, like immunotherapy using immune checkpoint inhibitors which, in combination with chemotherapy, has been shown to increase survival. In this article, we review the most relevant articles concerning GC prevention and treatment published between April 2020 and March 2021.
doi_str_mv 10.26355/mhd_20218_531
format article
fullrecord <record><control><sourceid>doaj</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_35d73d26fbe64596b32d57fb122c9789</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_35d73d26fbe64596b32d57fb122c9789</doaj_id><sourcerecordid>oai_doaj_org_article_35d73d26fbe64596b32d57fb122c9789</sourcerecordid><originalsourceid>FETCH-doaj_primary_oai_doaj_org_article_35d73d26fbe64596b32d57fb122c97893</originalsourceid><addsrcrecordid>eNqtjDFOAzEURC0kpESQNrUvEOL9Xq-9NRBBG9Fbf-2_iaOsHdlWIjruwA05CQFxBKqZN3oaxpaNeIBOKrWe9t6CgMZYJZsbNgct2pUxrZqxRSkHIQQYrYSQc_a0pXOgC__6-ORbchQrj3QpPEV-ynS-crhWjJ7XTFinHyGNfIel5uC4w-go37PbEY-FFn95x143z2-PLyuf8GBPOUyY323CYH-HlHcWcw3uSFYqr6WHbhyoa1XfDRK80uPQALhem17-59c3ojVaLg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Review – Recent news on prevention and treatment of gastric cancer</title><source>Directory of Open Access Journals</source><creator>G. Pasi ; T. Matysiak-Budnik</creator><creatorcontrib>G. Pasi ; T. Matysiak-Budnik</creatorcontrib><description>Despite its decreasing incidence, gastric cancer (GC) is still the third leading cause of cancer death in the world. Eradication of Helicobacter pylori has been shown to decrease the risk of GC, without evidence of adverse consequences. Operable GC is treated with surgery, and laparoscopic gastrectomy has proven to be a valid alternative to open gastrectomy. For advanced GC, the available therapies show limited benefit in extending survival, but some new approaches are emerging, like immunotherapy using immune checkpoint inhibitors which, in combination with chemotherapy, has been shown to increase survival. In this article, we review the most relevant articles concerning GC prevention and treatment published between April 2020 and March 2021.</description><identifier>EISSN: 2704-8845</identifier><identifier>DOI: 10.26355/mhd_20218_531</identifier><language>eng</language><publisher>Verduci Editore</publisher><subject>helicobacter pylori ; immunotherapy ; laparoscopy ; prevention ; screening</subject><ispartof>Microbiota in health and disease, 2021-08, Vol.3</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,2095,27903,27904</link.rule.ids></links><search><creatorcontrib>G. Pasi</creatorcontrib><creatorcontrib>T. Matysiak-Budnik</creatorcontrib><title>Review – Recent news on prevention and treatment of gastric cancer</title><title>Microbiota in health and disease</title><description>Despite its decreasing incidence, gastric cancer (GC) is still the third leading cause of cancer death in the world. Eradication of Helicobacter pylori has been shown to decrease the risk of GC, without evidence of adverse consequences. Operable GC is treated with surgery, and laparoscopic gastrectomy has proven to be a valid alternative to open gastrectomy. For advanced GC, the available therapies show limited benefit in extending survival, but some new approaches are emerging, like immunotherapy using immune checkpoint inhibitors which, in combination with chemotherapy, has been shown to increase survival. In this article, we review the most relevant articles concerning GC prevention and treatment published between April 2020 and March 2021.</description><subject>helicobacter pylori</subject><subject>immunotherapy</subject><subject>laparoscopy</subject><subject>prevention</subject><subject>screening</subject><issn>2704-8845</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNqtjDFOAzEURC0kpESQNrUvEOL9Xq-9NRBBG9Fbf-2_iaOsHdlWIjruwA05CQFxBKqZN3oaxpaNeIBOKrWe9t6CgMZYJZsbNgct2pUxrZqxRSkHIQQYrYSQc_a0pXOgC__6-ORbchQrj3QpPEV-ynS-crhWjJ7XTFinHyGNfIel5uC4w-go37PbEY-FFn95x143z2-PLyuf8GBPOUyY323CYH-HlHcWcw3uSFYqr6WHbhyoa1XfDRK80uPQALhem17-59c3ojVaLg</recordid><startdate>20210801</startdate><enddate>20210801</enddate><creator>G. Pasi</creator><creator>T. Matysiak-Budnik</creator><general>Verduci Editore</general><scope>DOA</scope></search><sort><creationdate>20210801</creationdate><title>Review – Recent news on prevention and treatment of gastric cancer</title><author>G. Pasi ; T. Matysiak-Budnik</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-doaj_primary_oai_doaj_org_article_35d73d26fbe64596b32d57fb122c97893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>helicobacter pylori</topic><topic>immunotherapy</topic><topic>laparoscopy</topic><topic>prevention</topic><topic>screening</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>G. Pasi</creatorcontrib><creatorcontrib>T. Matysiak-Budnik</creatorcontrib><collection>Directory of Open Access Journals</collection><jtitle>Microbiota in health and disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>G. Pasi</au><au>T. Matysiak-Budnik</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Review – Recent news on prevention and treatment of gastric cancer</atitle><jtitle>Microbiota in health and disease</jtitle><date>2021-08-01</date><risdate>2021</risdate><volume>3</volume><eissn>2704-8845</eissn><abstract>Despite its decreasing incidence, gastric cancer (GC) is still the third leading cause of cancer death in the world. Eradication of Helicobacter pylori has been shown to decrease the risk of GC, without evidence of adverse consequences. Operable GC is treated with surgery, and laparoscopic gastrectomy has proven to be a valid alternative to open gastrectomy. For advanced GC, the available therapies show limited benefit in extending survival, but some new approaches are emerging, like immunotherapy using immune checkpoint inhibitors which, in combination with chemotherapy, has been shown to increase survival. In this article, we review the most relevant articles concerning GC prevention and treatment published between April 2020 and March 2021.</abstract><pub>Verduci Editore</pub><doi>10.26355/mhd_20218_531</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 2704-8845
ispartof Microbiota in health and disease, 2021-08, Vol.3
issn 2704-8845
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_35d73d26fbe64596b32d57fb122c9789
source Directory of Open Access Journals
subjects helicobacter pylori
immunotherapy
laparoscopy
prevention
screening
title Review – Recent news on prevention and treatment of gastric cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T07%3A45%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-doaj&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Review%20%E2%80%93%20Recent%20news%20on%20prevention%20and%20treatment%20of%20gastric%20cancer&rft.jtitle=Microbiota%20in%20health%20and%20disease&rft.au=G.%20Pasi&rft.date=2021-08-01&rft.volume=3&rft.eissn=2704-8845&rft_id=info:doi/10.26355/mhd_20218_531&rft_dat=%3Cdoaj%3Eoai_doaj_org_article_35d73d26fbe64596b32d57fb122c9789%3C/doaj%3E%3Cgrp_id%3Ecdi_FETCH-doaj_primary_oai_doaj_org_article_35d73d26fbe64596b32d57fb122c97893%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true